Anti-cancer therapy development
The company develops therapies for clinical settings in areas of high unmet need.
Source: LinkedIn company description · Retrieved October 13, 2026
Cumulus Oncology is developing anti-cancer therapies for clinical settings in areas of high unmet need.
The company is backed by an entrepreneur in oncology and led by a team of senior professionals. Its team has experience in licensing and business development, oncology drug discovery, and pre-clinical and clinical development.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The company is interested in partnering with organisations that have late-discovery or clinical-stage oncology assets.
The company develops therapies for clinical settings in areas of high unmet need.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 2, 2026, September 4, 2026, September 14, 2026, September 15, 2026, September 16, 2026, September 17, 2026, September 18, 2026, September 19, 2026, September 21, 2026 and October 8, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.